Pancreatic malignancy: effect of dual-phase helical CT in tumor detection and vascular opacification

Radiology. 1997 Nov;205(2):513-8. doi: 10.1148/radiology.205.2.9356637.

Abstract

Purpose: To determine the relative value of hepatic arterial and portal venous phase helical computed tomographic (CT) scans for tumor detection and vascular opacification in patients with pancreatic malignancy.

Materials and methods: Ninety-five patients who had or were suspected of having pancreatic disease underwent dual-phase helical CT. Arterial phase scans were acquired 20-40 seconds after contrast material administration; venous phase scans, 70-100 seconds after administration. Three readers independently scored images in a blinded fashion for the presence of tumor, for lesion attenuation relative to normal pancreas, and for vascular opacification.

Results: The final diagnosis was pancreatic malignancy (n = 60), acute or chronic pancreatitis (n = 22), and normal pancreas (n = 13). The readers identified possible or definite tumors on arterial phase studies in 47-50 patients and on venous phase studies in 48-53 patients (P > .10). There was no statistically significant difference in tumor attenuation between scans from the two phases (P > .05). Agreement between the readers for tumor detection was not affected by the scanning phase (P > .10). Opacification of arteries and of veins was greater on arterial phase scans and on venous phase scans, respectively (P < .001).

Conclusion: The acquisition of arterial phase scans in addition to venous phase scans does not result in improved detection of pancreatic malignancies.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Contrast Media
  • Female
  • Hepatic Artery / diagnostic imaging
  • Humans
  • Male
  • Middle Aged
  • Pancreas / diagnostic imaging
  • Pancreatic Neoplasms / blood supply
  • Pancreatic Neoplasms / diagnostic imaging*
  • Pancreatitis / diagnostic imaging
  • Portal Vein / diagnostic imaging
  • ROC Curve
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed*

Substances

  • Contrast Media